CAMBRIDGE, Mass.--(BUSINESS WIRE)--Please note: the start time of the webcast has moved to 8:00 am ET.
Biogen Inc. (NASDAQ:BIIB) will report fourth quarter 2016 financial results on Thursday, January 26, 2017, before the financial markets open.
Following the release of the financials, the Company will host a live webcast where Biogen management will discuss the financial results, at 8:00 am ET. To access the live webcast, please go to the investor relations section of Biogen’s website at www.biogen.com/investors. Following the live webcast, an archived version of the call will be available at the same URL.
About Biogen
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For more information, please visit www.biogen.com. Follow us on Twitter.
Contact:
Biogen
Karen Jewell, 781-464-2442
Investor Relations
